Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Dosing commenced in Phase 2 trial for Pharmaxis’ lead asset myelofibrosis drug
    • News

    Dosing commenced in Phase 2 trial for Pharmaxis’ lead asset myelofibrosis drug

    With a share price that has effectively doubled over the past few months and a drug pipeline beginning to snowball its successes, investors that identified Pharmaxis (ASX: PXS) early on are justifiably ecstatic. The clinical stage drug developers have had a strong start to FY22 with their lead asset, oncology drug PXS-5505 and anti-skin scarring

    Read More
    Public
  • Rising death rates Propel demand for funeral services
    • News

    Rising death rates Propel demand for funeral services

    Despite the awkwardness of a pandemic with death being talked about more than ever, Propel Funeral Partners (ASX: PFP) have been diligently handling the sensitivity of increasing death rates which has resulted in greater demand for funeral services. For the Quarter ended 30 September 2021, Propel has reported a 13% increase in revenue compared to

    Read More
    Public
  • Hidden gems: the profitable small caps forging export markets
    • Opinion

    Hidden gems: the profitable small caps forging export markets

    As with so many facets of human nature, it’s natural for investors to covet the next big thing wrapped in glittering paper. It’s why tech stocks have done so well in recent years, as well as anything related to battery metals or the buy-now-pay-later sector. It’s also why home-grown hero Canva is valued at a

    Read More
    Public
  • Goodbye lounge room gym! Viva Leisure expands portfolio just in time for lockdown lift
    • News

    Goodbye lounge room gym! Viva Leisure expands portfolio just in time for lockdown lift

    If you’re like me you’re probably a bit over using your lounge room as an office, cinema, dining room and gym. The multidisciplinary heart of my home is often littered with dumbbells, yoga mats, wine glasses and whatever book I’m currently reading. It’s an odd picture.  The thought of getting back into a real gym,

    Read More
    Public
  • Classified: XTEK receives $1.5m order for ballistic armour from US Government
    • News

    Classified: XTEK receives $1.5m order for ballistic armour from US Government

    An undisclosed US Federal Government department is set to beef up its protection with the order of $1.5 million worth of specialist ballistic armour products from defence manufacturer XTEK (ASX: XTE).  The $1.5m order (USD $1.1m) was placed with XTEK’s wholly-owned subsidiary HighCom Armor Solutions which specialises in advanced ballistic body armour.  “By leveraging advanced

    Read More
    Public
  • Major bank backs neolender Wisr with new $225m vehicle loan warehouse
    • News

    Major bank backs neolender Wisr with new $225m vehicle loan warehouse

    If you can’t beat them, join them. This is exactly what one unnamed Big 4 bank is doing with neolender Wisr (ASX: WZR) as the senior funder of their new $225 million vehicle financing warehouse as more Australians transition away from traditional banking.  The new warehouse will upsize Wisr’s existing $127m facility which will be

    Read More
    Public
  • «
  • ‹
  • 450
  • 451
  • 452
  • 453
  • 454
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.